These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28483250)

  • 1. Monophosphoryl lipid A enhances nontypeable Haemophilus influenzae-specific mucosal and systemic immune responses by intranasal immunization.
    Iwasaki T; Hirano T; Kodama S; Kadowaki Y; Moriyama M; Kawano T; Suzuki M
    Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():5-12. PubMed ID: 28483250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monophosphoryl lipid A induced innate immune responses via TLR4 to enhance clearance of nontypeable Haemophilus influenzae and Moraxella catarrhalis from the nasopharynx in mice.
    Hirano T; Kodama S; Kawano T; Maeda K; Suzuki M
    FEMS Immunol Med Microbiol; 2011 Dec; 63(3):407-17. PubMed ID: 22092567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Toll-like receptor 4 in eliciting acquired immune responses against nontypeable Haemophilus influenzae following intranasal immunization with outer membrane protein.
    Hirano T; Kodama S; Moriyama M; Kawano T; Suzuki M
    Int J Pediatr Otorhinolaryngol; 2009 Dec; 73(12):1657-65. PubMed ID: 19765832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
    Sabirov A; Kodama S; Hirano T; Suzuki M; Mogi G
    Infect Immun; 2001 May; 69(5):2964-71. PubMed ID: 11292713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S; Hirano T; Noda K; Abe N; Suzuki M
    Vaccine; 2010 Mar; 28(13):2510-6. PubMed ID: 20117272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
    Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intranasal immunization on protective immunity against otitis media.
    Kurono Y; Suzuki M; Mogi G; Yamamoto M; Fujihashi K; McGhee JR; Kiyono H
    Int J Pediatr Otorhinolaryngol; 1999 Oct; 49 Suppl 1():S227-9. PubMed ID: 10577810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx.
    Hirano T; Hou Y; Jiao X; Gu XX
    FEMS Immunol Med Microbiol; 2003 Jan; 35(1):1-10. PubMed ID: 12589951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae.
    Hotomi M; Yamanaka N; Shimada J; Suzumoto M; Ikeda Y; Sakai A; Arai J; Green B
    Int J Pediatr Otorhinolaryngol; 2002 Sep; 65(2):109-16. PubMed ID: 12176180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
    Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin.
    Hotomi M; Saito T; Yamanaka N
    Vaccine; 1998 Dec; 16(20):1950-6. PubMed ID: 9796049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
    Bertot GM; Becker PD; Guzmán CA; Grinstein S
    J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice.
    Cutter D; Mason KW; Howell AP; Fink DL; Green BA; St Geme JW
    J Infect Dis; 2002 Oct; 186(8):1115-21. PubMed ID: 12355362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx.
    Abe N; Kodama S; Hirano T; Eto M; Suzuki M
    Laryngoscope; 2006 Mar; 116(3):407-12. PubMed ID: 16540899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal-associated lymphoid tissue immunity and vaccine development.
    Kodama S; Suzuki M
    Adv Otorhinolaryngol; 2011; 72():110-2. PubMed ID: 21865705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice.
    Michel LV; Kaur R; Zavorin M; Pryharski K; Khan MN; LaClair C; O'Neil M; Xu Q; Pichichero ME
    J Med Microbiol; 2018 Oct; 67(10):1527-1532. PubMed ID: 30136923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx.
    Noda K; Kodama S; Umemoto S; Abe N; Hirano T; Suzuki M
    Vaccine; 2010 Jul; 28(31):5068-74. PubMed ID: 20478344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of nasal clearance of nontypeable Haemophilus influenzae by oral immunization with outer membrane proteins.
    Suzuki M; Kurono Y; Kodama S; Shigemi H; Mogi G
    Acta Otolaryngol; 1998 Nov; 118(6):864-9. PubMed ID: 9870635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Mucosal IgA-Mediated Protective Immunity Against Nontypeable
    Nakahashi-Ouchida R; Mori H; Yuki Y; Umemoto S; Hirano T; Uchida Y; Machita T; Yamanoue T; Sawada SI; Suzuki M; Fujihashi K; Akiyoshi K; Kurono Y; Kiyono H
    Front Immunol; 2022; 13():819859. PubMed ID: 35874779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.